International Congress of Virology, Sapporo, ASV Travel Request

描述（由申请人提供）： 摘要 主要研究者：SAWICKI，DOROTHEA L 项目：1 R13 AI 091185 -01标题：国际病毒学大会，札幌，ASV旅行申请登录号：3253449 ================== 注意事项：本摘要摘自应用程序，未经SRA验证。当应用程序扫描过程出现问题时，提取的文本可能不正确或不完整。 ================== 美国病毒学学会希望通过这笔整笔赠款，为20名入选的优秀初级病毒学家参加将于2011年9月11日至16日举行的第十五届国际病毒学大会（ICV）提供部分差旅费支持，每个奖项1，500美元，总计30，000美元。这个三年一度的国际会议将在日本的札幌举行，它对美国来说是必不可少的。S.由最优秀的初级病毒学家代表ICV是美国初级研究人员与国际公认的病毒学家专家直接会面和互动的独特机会，并在全体会议，研讨会和海报会议上了解所有病毒研究领域的最新发展，包括人类，动物，植物，昆虫和原核生物的病毒。目前的问题，在临床病毒学，艾滋病和丙型肝炎病毒，和新认识的逆转录病毒（慢性疲劳），细小病毒和冠状病毒，将包括在内。会议将涵盖病毒进入和结构，病毒-细胞相互作用，进化，免疫生物学，发病机制，病毒与宿主防御，病毒复制和复制的宿主因素，新兴病毒和病毒控制，诊断和疫苗等。研讨会和海报会议将讨论所有病毒家族及其复制和发病机制。ASV认为，激励和帮助初级病毒学家在未来工作中的一个很好的方法是使他们能够与世界各地最好的病毒学家直接互动，从而经常产生独特的，持久的合作。如果NIH研究所/项目提供资金支持初级病毒学家前往第十五届ICV，ASV总裁和候任总裁Goldin博士和Dermody博士将分别组织遴选委员会，以选择将出席并从旅行奖励中受益最多的申请人。成功的申请人将需要一份令人满意的会后报告，详细说明其研究的好处。我们的目标是为初级病毒学家提供部分资金，包括女性和少数民族科学家，否则他们可能无法参加大会，目的是使美国的病毒学研究受益。S. A.在未来的岁月里。病毒学研究可应用于感染、免疫、肿瘤、血液、肺、心血管、胃肠道、神经、眼科、儿童和慢性疾病、基础遗传学和生物技术。

DESCRIPTION (provided by applicant): Abstract PI: SAWICKI, DOROTHEA L Project: 1R13AI091185-01 Title: International Congress of Virology, Sapporo, ASV Travel Request Accession Number: 3253449 ================== NOTICE: THIS ABSTRACT WAS EXTRACTED FROM APPLICATION AND HAS NOT BEEN PROOFED BY AN SRA.WHEN THERE ARE PROBLEMS WITH THE APPLICATION SCANNING PROCESS, THE EXTRACTED TEXT MAY BE INCORRECT OR INCOMPLETE. ================== The American Society for Virology wishes to provide, through this block grant, partial support for the travel of 20 selected outstanding junior virologists to participate in the XVth International Congress of Virology (ICV) to be held September 11-16, 2011, at a level of $1,500 per award, for a $30,000 total. This triennial ICV will be in Sapporo, Japan, and it is essential for the U. S. to be represented by its best junior virologists. The ICV is a unique opportunity for U.S. junior investigators to meet and interact directly with internationally recognized expert virologists as well as learn in plenary sessions, workshops and poster sessions the most recent developments in all virus research areas, including viruses of humans, animals, plants, insects, and prokaryotes. Current problems in clinical virology, AIDS and HCV, and newly recognized retroviruses (chronic fatigue), parvoviruses and coronaviruses, will be included. Sessions will cover virus entry and structure, virus-cell interactions, evolution, immunobiology, pathogenesis, virus versus host defenses, virus replication and host factors for replication, emerging viruses and viral control, diagnostics and vaccines, among others. Workshop and poster sessions will address all virus families and their replication and pathogenesis. ASV considers one excellent way to stimulate and aid junior virologists in their future work is to enable them to interact directly with the best virologists world-wide, from which unique, long-lasting collaborations often result. If funds are provided by NIH institutes/programs to support travel of junior virologists to the XVth ICV, Drs. -Goldin and Dermody, President and President-elect of ASV, respectively, will organize the Selection Committee to choose applicants who will present and benefit most from the travel award. A satisfactory post-meeting report detailing the benefits to their research will be required of successful applicants. Our aim is to provide partial funding for junior virologists, including women and minority scientists, who might otherwise be unable to attend the Congress, with the goal of benefiting virological research in the U. S. A. for years to come. Virological research has applications for infectious, immunologic, neoplastic, hematologic, pulmonary, cardiovascular, GI, neurologic, ophthalmologic, childhood and chronic diseases, basic genetics and biotechnology.